# Adenosine

NDC: 55150-193
Generic name: Adenosine
Labeler / Manufacturer: Eugia US LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20171102

FDA application: ANDA205331

## Active ingredients

- ADENOSINE: 90 mg/30mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55150-193"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55150-193
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=61d9b8f6-f93f-46ee-bec2-db8d46999792